These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 9494699)

  • 1. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man.
    Mazza E; Ghigo E; Bellone J; Arvat E; Revelli E; Cella SG; Brambilla F; Müller EE; Camanni F
    Endocrinol Exp; 1990 Mar; 24(1-2):211-9. PubMed ID: 1972919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa.
    Rolla M; Andreoni A; Belliti D; Ferdeghini M; Cristofani R; Müller EE
    Endocrinol Exp; 1990 Mar; 24(1-2):195-204. PubMed ID: 2113857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
    Gianotti L; Fassino S; Daga GA; Lanfranco F; De Bacco C; Ramunni J; Arvat E; MacCario M; Ghigo E
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):713-20. PubMed ID: 10848875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhibition of the hypothalamic somatostatinergic tone is not the cause of the enhanced growth hormone response to growth hormone-releasing hormone in patients with liver cirrhosis.
    Fanciulli G; Tomasi PA; Giusti M; Bertoncelli A; Deplano A; Garrucciu G; Delitala G
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):148-51. PubMed ID: 18095239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
    Pincelli AI; Rigamonti AE; Scacchi M; Cella SG; Cappa M; Cavagnini F; Müller EE
    Eur J Endocrinol; 2003 Feb; 148(2):237-43. PubMed ID: 12590644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus.
    Martina V; Miola C; Maccario M; Talliano M; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1992 Nov; 24(11):520-3. PubMed ID: 1333441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.
    Mancini A; Bianchi A; Tacchino RM; Perrelli M; Milardi D; Gentilella R; Giampietro A; Fusco A; Valle D; De Marinis L
    Metabolism; 2001 Apr; 50(4):382-6. PubMed ID: 11288030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H; Komaki G; Matsubayashi S; Kobayashi N; Mori K; Nakagawa T; Truong MP; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man.
    Arvat E; Gianotti L; Ramunni J; DiVito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Jan; 19(1):25-9. PubMed ID: 8851688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
    Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M
    Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
    Valcavi R; Zini M
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.